Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics ; volume:25 ; number:5 ; day:11 ; month:9 ; year:2023 ; pages:1-12 ; date:9.2023
The AAPS journal / American Association of Pharmaceutical Scientists ; 25, Heft 5 (11.9.2023), 1-12, 9.2023
- Creator
-
Haltaufderhyde, Kirk
Roberts, Brian J.
Khan, Sundos
Terry, Frances
Boyle, Christine M.
McAllister, Mitchell
Martin, William
Rosenberg, Amy
Groot, Anne S. De
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1208/s12248-023-00852-z
- URN
-
urn:nbn:de:101:1-2024030321072587459969
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Haltaufderhyde, Kirk
- Roberts, Brian J.
- Khan, Sundos
- Terry, Frances
- Boyle, Christine M.
- McAllister, Mitchell
- Martin, William
- Rosenberg, Amy
- Groot, Anne S. De
- SpringerLink (Online service)
Other Objects (12)
Correction to: Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Immunogenicity Risk Assessment for Multi-specific Therapeutics
FDA efficiency for approval process of COVID-19 therapeutics
Biologic basis of pigmentation
Transplantation therapeutics
Arithmetical therapeutics
Antibody therapeutics
Advanced therapeutics
Emerging therapeutics
Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor
Biologic system evaluation with ultrasound
Correction to: Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Immunogenicity Risk Assessment for Multi-specific Therapeutics
FDA efficiency for approval process of COVID-19 therapeutics
Biologic basis of pigmentation
Transplantation therapeutics
Arithmetical therapeutics
Antibody therapeutics
Advanced therapeutics
Emerging therapeutics
Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor
Biologic system evaluation with ultrasound
Correction to: Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Immunogenicity Risk Assessment for Multi-specific Therapeutics
FDA efficiency for approval process of COVID-19 therapeutics
Biologic basis of pigmentation
Transplantation therapeutics
Arithmetical therapeutics
Antibody therapeutics
Advanced therapeutics
Emerging therapeutics
Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor